Switching stories: user testimonials on juul.com continue to contradict JUUL's switch ≠ cessation narrative
- PMID: 33154067
- PMCID: PMC8096851
- DOI: 10.1136/tobaccocontrol-2020-055816
Switching stories: user testimonials on juul.com continue to contradict JUUL's switch ≠ cessation narrative
Abstract
Background: In January 2019, electronic nicotine delivery systems (ENDS) market leader Juul Labs (JUUL) launched an advertising campaign encouraging adult smokers to 'make the switch' from combustible cigarettes to JUUL. Our primary aim was to describe consumer perceptions of JUUL as communicated by members of JUUL's online social community via testimonials promoted on JUUL's website.
Methods: User testimonials that were displayed on the JUUL website in December 2019 and January 2020 were collected and coded by three reviewers. A total of 220 testimonials were coded for primary and secondary themes (eight codes within four broader themes).
Results: Testimonial writers were, on average, 43.0 years old (range 28 to 74) and reported using JUUL for an average of 21.8 months (range 9 to 59 months). The most prominent theme, present in nearly half of the testimonials, was a description of how to use JUUL, with a mention of JUUL's benefits and tips on how to use the product. Nearly four in 10 statements encouraged smokers to give JUUL a try or noted that JUUL is a better product compared with cigarettes. About one in 10 statements focused on switching from smoking cigarettes to using JUUL.
Conclusion: This study presents a foundation for understanding how adult users describe JUUL, including their experiences using JUUL to 'switch' or stop smoking. Currently, the effectiveness of ENDS for smoking cessation is not supported by substantial evidence; however, if cessation is defined as 'quitting combustible tobacco products', then regulators should be aware that switch and cessation messages may not be distinct.
Keywords: advertising and promotion; electronic nicotine delivery devices; public policy.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
References
-
- U.S. Food and Drug Administration. Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Products; Amendments to Regulations Regarding “Intended Uses, ” 82 Fed. Reg. 2193, 2198, 2200 (January. 9, 2017). - PubMed
-
- Centers for Disease Control and Prevention. Transcript of December 20, 2019, Telebriefing: Update on Lung Injury Associated with E-cigarette Use, or Vaping: U.S. Department of Health and Human Services, 2019.
-
- Dodge B How JUUL went from a successful startup to FDA target in less than a year. Newsweek 2019. https://www.newsweek.com/timeline-juul-turbulent-year-ponders-selling-of... (accessed March 20, 2020).
-
- Ducharme J, Li A. How Juul Hooked Kids and Ignited a Public Health Crisis. Time 2019. [published Online First: September 19, 2019]
-
- U.S. Food and Drug Administration. Deeming Tobacco Products to Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical